Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.305    0.03 (0.70%)
Bid:
4.20
Ask:
4.32
Spread: 0.12 (2.857%)
Market Cap: £206.62m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Automotive progress

18 Sep 2006 11:24

Seeing Machines Limited18 September 2006 18 September 2006 Seeing Machines Limited ("Seeing Machines" or the "Company") SEEING MACHINES MAKES STRONG PROGRESS IN AUTOMOTIVE MARKET DRIVER FATIGUE AND DISTRACTION SYSTEM COMMENCE SECOND PHASE FIELD TRIAL Seeing Machines (AIM : SEE) announce the commencement of the second phase fieldtrial of the driver fatigue, distraction and state sensor system ("DSS") inassociation with a major oil field services and mining company in Texas, USA.In a collaborative effort with our technology commercialization partner, HellaKGaA Hueck & Co ("Hella"), Seeing Machines is testing the technology under realworld operating conditions. This second phase trial builds on the initial phase that has been run over thelast 6 months with Seeing Machines' Texan Partners. That work has inspired anumber of refinements and optimizations of the DSS-Research product that are nowbeing tested. Nick Cerneaz, CEO, Seeing Machines said: "Putting the device into the hands of afleet operator working under such harsh conditions is allowing us to iron anyremaining issues before we proceed to the general release of the product in thenear future. We are enthused with the progress of the testing to date and verymuch look forward to this next phase." The DSS-Research Product will be released in Q4 2006 and is targeted atgovernment, university and fleet manager multi-car fleet trials / research. AutocRC PrOJECT Agreement SIGNED Seeing Machines announces the execution of an agreement for research,development and commercialisation into vision based collision avoidanceapplications with the Co-operative Research Centre for Advanced AutomotiveTechnology Ltd. ("AutoCRC"). Seeing Machines had earlier agreed to become aResearch Participant in the AutoCRC, and this agreement constitutes theformation of a specific project and programme of work within that framework. The vision based collision avoidance project is a collaborative project lead bySeeing Machines and includes Latrobe University and the Australian NationalUniversity as R&D participants along with GM Holden and Australian Arrow asindustry participants. Seeing Machines will receive A$788k for work on the project through to September2008. This project is initially focused on speed sign recognition, and throughthe remainder of the AutoCRC's seven year lifespan, additional funding may bemade available to address a range of other safety issues such as pedestriandetection and integrated lane departure warning. Nick Cerneaz, CEO, Seeing Machines said "The AutoCRC is a tremendous frameworkto support the development of advanced technology that requires contributionsfrom a wide spectrum of academic, technology and commercial partners, leveragingthe best each party has to offer. The computer vision based collision avoidancesystems being developed in this program dovetail nicely with the strategies ofour own automotive business and we are consequently keen supporters of thisprogramme." The AutoCRC was established as part of the Australian Federal Government's CRCProgram initiative. For more information on the CRC Program see https://www.crc.gov.au/Information/default.aspx. For more information on the AutoCRCsee www.autocrc.com. --- ENDS --- Enquiries: Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713 www.seeingmachines.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Dec 20237:00 amRNSSeeing Machines announces US$30M European OEM win
13th Dec 20238:02 amRNSSeeing Machines welcomes U.S. NHTSA announcement
12th Dec 20237:00 amRNSSeeing Machines Wins Prestigious Road Safety Award
29th Nov 20237:57 amRNSResult of AGM
24th Nov 20237:00 amRNSAGM – reminder and correction of login details
8th Nov 20237:00 amRNS16th Automotive program awarded & Q1 FY2024 KPIs
6th Nov 202311:26 amRNSDirector/PDMR Shareholding
31st Oct 202311:50 amRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSNotice of AGM
27th Oct 20237:19 amRNSDirector/PDMR Shareholding
27th Oct 20237:13 amRNSDirector/PDMR Shareholding
25th Oct 20237:55 amRNSDirector/PDMR Shareholding
25th Oct 20237:00 amRNSBoard Changes
20th Oct 20239:30 amRNSDirector/PDMR Shareholding
20th Oct 20239:21 amRNSDirector/PDMR Shareholding
19th Oct 20238:47 amRNSDirector/PDMR Shareholding
18th Oct 202310:06 amRNSDirector/PDMR Shareholding
17th Oct 20239:41 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSYear End Results – FY2023
16th Oct 20237:00 amRNSDevelopment of aviation fatigue detection solution
14th Sep 20237:00 amRNSNotice of Full Year Results 2023
7th Sep 20235:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSFY2023 Trading Update & Q4 KPIs
18th Jul 20237:30 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSCEO Incentive Plan
28th Jun 20231:44 pmRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
26th Jun 202311:38 amRNSDirector/PDMR Shareholding
23rd Jun 20238:55 amRNSDirector/PDMR Shareholding
20th Jun 20237:30 amRNSCollaboration with synthetic data specialist
19th Jun 20238:00 amRNSSeeing Machines to attend Stifel Tech Conference
25th May 20239:53 amRNSDirector/PDMR Shareholding
22nd May 20239:46 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSExclusive Agreement Signed with Collins Aerospace
4th May 20237:00 amRNSKey Performance Indicators Q3 FY2023
17th Apr 20239:29 amRNSDirector/PDMR Shareholding
13th Apr 202312:36 pmRNSDirector/PDMR Shareholding
11th Apr 202311:15 amRNSPDMR Shareholding
6th Apr 20232:45 pmRNSDirector/PDMR Shareholding
5th Apr 20239:08 amRNSPDMR Shareholding
31st Mar 202312:26 pmRNSPDMR Shareholding
29th Mar 202311:55 amRNSDirector/PDMR Shareholding
28th Mar 202311:28 amRNSPDMR Shareholding
27th Mar 202310:12 amRNSDirector/PDMR Shareholding
27th Mar 202310:07 amRNSDirector/PDMR Shareholding
24th Mar 202311:56 amRNSPDMR Shareholding
24th Mar 20238:59 amRNSDirector/PDMR Shareholding
22nd Mar 20239:16 amRNSPDMR Shareholding
17th Mar 20239:03 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.